| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.96B | -3.0% |
| Cost of Revenue | $1.84B | -4.9% |
| Gross Profit | $1.12B | +0.4% |
| R&D Expense | $32.9M | -5.2% |
| SG&A Expense | $489.4M | +1.0% |
| Interest Expense | $168.7M | +6.5% |
| Pre-tax Income | $175.7M | +157.5% |
| Income Tax | $35.2M | +147.6% |
| Net Income | $140.5M |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223.3M | +8.8% |
| Accounts Receivable | $511.6M | +21.3% |
| Inventory | $649.7M | -15.8% |
| Current Assets | $1.56B | -2.1% |
| Total Assets | $4.51B | -1.4% |
| Current Liabilities | $734.2M | +5.2% |
| Long-term Debt | $3.38B | -4.9% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $395.2M | — |
| Capital Expenditures | $56.8M | -27.0% |
| Investing Cash Flow | -$56.1M | +38.3% |
| Financing Cash Flow | -$309.4M | -491.2% |
| Free Cash Flow | $338.4M | +540.6% |
| +160.7% |
| EPS (Basic) | $1.97 | +158.5% |
| EPS (Diluted) | $1.94 | +157.6% |
| Total Liabilities |
| $4.30B |
| -3.2% |
| Stockholders' Equity | $210.7M | +61.3% |